RVL Pharmaceuticals plc Current Foreign Tax Expense (Benefit)
RVL Pharmaceuticals plc reported Current Foreign Tax Expense (Benefit) of $68.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-20.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentForeignTaxExpenseBenefit · last filed 2023-03-20
- RVL Pharmaceuticals plc current foreign tax expense (benefit) for fiscal 2022 was $68.00K.
- RVL Pharmaceuticals plc current foreign tax expense (benefit) for fiscal 2021 was -$20.00K.
- RVL Pharmaceuticals plc current foreign tax expense (benefit) for fiscal 2020 was -$80.00K.
- RVL Pharmaceuticals plc current foreign tax expense (benefit) for fiscal 2018 was $2.09M.
| Period end | Current Foreign Tax Expense (Benefit) 12 month | Current Foreign Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2022-12-31 | $68.00K 10-K · filed 2023-03-20 | |
| 2021-12-31 | -$20.00K 10-K · filed 2023-03-20 | |
| 2020-12-31 | -$80.00K 10-K · filed 2022-03-30 | $985.00K 10-K · filed 2021-03-30 |
| 2019-12-31 | -$2.85M 8-K · filed 2021-09-08 | $791.00K 10-K · filed 2020-03-19 |
| 2018-12-31 | $2.09M 10-K · filed 2020-03-19 | $1.81M 10-K · filed 2019-03-28 |
| 2017-12-31 | $1.60M 8-K · filed 2019-12-20 |